ArticleFrontiers in immunology2023

Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager.

Xinghui Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.